A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Conformational Heterogeneity of Surface-Grafted Amyloidogenic Fragments of Alpha-Synuclein Dimers Detected by Atomic Force Microscopy

Ray, C., & Akhremitchev, B. B. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052932e · Cited by 34

α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox

Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 35

Autophagy in α-Synucleinopathies—An Overstrained System

Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 36

Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies

Vivacqua, G., Yin, J.-J., Casini, A., Li, X., Li, Y.-H., D’Este, L., Chan, P., Renda, T. G., & Yu, S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.001 · Cited by 33

Impairment of microtubule system increases α-synuclein aggregation and toxicity

Kim, M., Jung, W.-S., Lee, I., Bhak, G., Paik, S. R., & Hahn, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.020 · Cited by 33

Development of New Treatments for Parkinson’s Disease in Transgenic Animal Models: A Role for β-Synuclein

Masliah, E., & Hashimoto, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00029-3 · Cited by 33

Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L

McGlinchey, R. P., Dominah, G. A., & Lee, J. C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00360 · Cited by 33

Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice

Rutherford, N. J., Dhillon, J.-K. S., Riffe, C. J., Howard, J. K., Brooks, M., & Giasson, B. I. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx371 · Cited by 33

The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?

Killinger, B. A., & Labrie, V. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191703 · Cited by 36

The Non-amyloidal Component Region of α-Synuclein Is Important for α-Synuclein Transport Within Axons

Anderson, E. N., Hirpa, D., Zheng, K. H., Banerjee, R., & Gunawardena, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00540 · Cited by 32

A unifying framework for amyloid-mediated membrane damage: The lipid-chaperone hypothesis

Tempra, C., Scollo, F., Pannuzzo, M., Lolicato, F., & Rosa, C. L. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140767 · Cited by 32

Truncation or proteolysis of α-synuclein in Parkinsonism

Suthar, S. K., & Lee, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101978 · Cited by 34

Cross Dimerization of Amyloid-β and αSynuclein Proteins in Aqueous Environment: A Molecular Dynamics Simulations Study

Jose, J. C., Chatterjee, P., & Sengupta, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106883 · Cited by 32

Common molecular pathogenesis of disease-related intrinsically disordered proteins revealed by NMR analysis

Shigemitsu, Y., & Hiroaki, H. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx056 · Cited by 34

Relative Importance of Hydrophobicity, Net Charge, and Secondary Structure Propensities in Protein Aggregation

Chiti, F. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_3 · Cited by 33

An alternatively spliced form of rodent α-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in α-synuclein aggregation

McLean, P. J., & Hyman, B. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00154-4 · Cited by 32

β‐Synuclein exhibits chaperone activity more efficiently than α‐synuclein

Lee, D., Paik, S. R., & Choi, K. Y. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.075 · Cited by 32

α-Synuclein: Experimental PathologyPreprint

Hasegawa, M., Nonaka, T., & Masuda‐Suzukake, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024273 · Cited by 33

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy

Siwecka, N., Saramowicz, K., Galita, G., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082051 · Cited by 33

HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species

Chen, S., Puri, A., Bell, B., Fritsche, J., Palacios, H. H., Balch, M., Sprunger, M. L., Howard, M. K., Ryan, J. J., Haines, J. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46538-8 · Cited by 32

Familial Mutations May Switch Conformational Preferences in α-Synuclein Fibrils

Xu, L., Ma, B., Nussinov, R., & Thompson, D. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00406 · Cited by 31

Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease

Pan, P., Zhu, Y., Shen, Y., & Yue, Z. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.020 · Cited by 33

Late-stage peptide and protein modifications through phospha-Michael addition reaction

He, P., Chen, H., Hu, H., Hu, J., Lim, Y., & Li, Y. (2020) · Chemical Communications · doi:10.1039/d0cc04969g · Cited by 31

A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation

Liang, Z., Chan, H. Y. E., Lee, M. M., & Chan, M. K. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2020.12.010 · Cited by 31

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

Hartlage‐Rübsamen, M., Bluhm, A., Moceri, S., Machner, L., Köppen, J., Schenk, M., Hilbrich, I., Holzer, M., Weidenfeller, M., Richter, F., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02349-5 · Cited by 31

Parkinson's disease as a member of Prion-like disorders

Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 33

Contribution of Alanine-76 and Serine Phosphorylation inα-Synuclein Membrane Association and Aggregation in Yeasts

Fiske, M., Valtierra, S., Solvang, K., Zorniak, M., White, M., Herrera, S., Konnikova, A., Brezinsky, R., & DebBurman, S. K. (2011) · Parkinson s Disease · doi:10.4061/2011/392180 · Cited by 32

Developing intrabodies for the therapeutic suppression of neurodegenerative pathology

Messer, A. C., Lynch, S. M., & Butler, D. C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903176387 · Cited by 32

Tilted properties of the 67–78 fragment of α‐synuclein are responsible for membrane destabilization and neurotoxicity

Crowet, J., Lins, L., Dupiereux-Fettweis, I., Elmoualija, B., Lorin, A., Charloteaux, B., Stroobant, V., Heinen, E., & Brasseur, R. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21483 · Cited by 30

Hydralazine Modifies Aβ Fibril Formation and Prevents Modification by Lipids in Vitro

Maheshwari, M., Roberts, J. K., DeSutter, B., Duong, K. T., Tingling, J. D., Fawver, J. N., Schall, H. E., Kahle, M., & Murray, I. V. J. (2010) · Biochemistry · doi:10.1021/bi101249p · Cited by 32

α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species

Morgan, S., Lavenir, I., Fan, J., Masuda‐Suzukake, M., Passarella, D., Deture, M. A., Dickson, D. W., Ghetti, B. F., & Goedert, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012179 · Cited by 31

α-Synuclein Aggregation and Modulating Factors

Paleologou, K. E., & El‐Agnaf, O. M. A. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_6 · Cited by 33

Coumarin 6 and 1,6-diphenyl-1,3,5-hexatriene (DPH) as fluorescent probes to monitor protein aggregation

Makwana, P. K., Jethva, P. N., & Roy, I. (2011) · The Analyst · doi:10.1039/c0an00829j · Cited by 32

Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions

Zeng, H., Liu, Y., Liu, X., Li, J., Lu, L., Cheng, X., Wu, X., Zhang, X., Zheng, Z., & Lu, G. (2024) · Inflammation · doi:10.1007/s10753-024-02156-6 · Cited by 31

Dopamine promotes the neurodegenerative potential of β‐synuclein

Raina, A., Leite, K., Darvas, S. G., Mahajani, S. U., Chakrabarti, K. S., Voll, D., Becker, S., Griesinger, C., Bähr, M., & Kügler, S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15134 · Cited by 29

Unraveling the NaCl Concentration Effect on the First Stages of α-Synuclein Aggregation

Ramis, R., Ortega‐Castro, J., Vilanova, B., Adrover, M., & Frau, J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01292 · Cited by 30

Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

Lloyd, G. M., Dhillon, J.-K. S., Gorion, K.-M. M., Riffe, C. J., Fromholt, S., Xia, Y., Giasson, B. I., & Borchelt, D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00486-9 · Cited by 29

The amyloid state of proteins: A boon or bane?

Hassan, M. N., Nabi, F., Khan, A. N., Hussain, M. S., Siddiqui, W. A., Uversky, V. N., & Khan, R. H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.115 · Cited by 30

The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease

Conway, J. A., Kinsman, G., & Kramer, E. R. (2022) · Genes · doi:10.3390/genes13030513 · Cited by 30

Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease

Sivakumar, P., Nagashanmugam, K. B., Priyatharshni, S., Lavanya, R., Prabhu, N., & Ponnusamy, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105461 · Cited by 29

The Clustering and Spatial Arrangement of β-Sheet Sequence, but Not Order, Govern α-Synuclein Fibrillogenesis

Suk, J.-E., Lokappa, S. B., & Ulmer, T. S. (2010) · Biochemistry · doi:10.1021/bi901753h · Cited by 29

Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis

Kamiyoshihara, T., Kojima, M., Uéda, K., Tashiro, M., & Shimotakahara, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.162 · Cited by 29

Structural Role of Compensatory Amino Acid Replacements in the α-Synuclein Protein

Losasso, V., Pietropaolo, A., Claudio Zannoni, A., Gustincich, S., & Carloni, P. (2011) · Biochemistry · doi:10.1021/bi2007564 · Cited by 29

Membrane-Bound Alpha Synuclein Clusters Induce Impaired Lipid Diffusion and Increased Lipid Packing

Iyer, A., Schilderink, N., Claessens, M. M. A. E., & Subramaniam, V. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.10.016 · Cited by 29

The fold preference and thermodynamic stability of α-synuclein fibrils is encoded in the non-amyloid-β component region

Xu, L., Bhattacharya, S., & Thompson, D. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp08321a · Cited by 29

Mechanistic Insights into Polyphenols’ Aggregation Inhibition of α-Synuclein and Related Peptides

Martins, G. F., Nascimento, C., & Galamba, N. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00162 · Cited by 28

Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health

Uytterhoeven, V., Verstreken, P., & Nachman, E. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202409104 · Cited by 29

Crocin Inhibits the Fibrillation of Human α-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation

Saffari, B., & Amininasab, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00379 · Cited by 28

Second Sphere Interactions in Amyloidogenic Diseases

Roy, M., Nath, A. K., Pal, I., & Dey, S. G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00941 · Cited by 29

Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology

Jiang, Y., Lin, Y., Krishnaswamy, S., Pan, R., Wu, Q., Sandusky‐Beltran, L. A., Liu, M., Kuo, M., Kong, X., Congdon, E. E., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf3775 · Cited by 29

Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies

Chua, C. E. L., & Tang, B. L. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.03.002 · Cited by 28

Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons

Wang, S., Chu, C., Guo, M., Jiang, L., Nie, H., Zhang, W., Wilson, B. C., Li, Y., Stewart, T., Hong, J., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0606-7 · Cited by 28

Synucleinopathies: a pathological and molecular review

Murray, I. V. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00023-8 · Cited by 28

Fibril fuzzy coat is important for α-synuclein pathological transmission activity

Han, Y., Li, J., Xia, W., Li, Q., Sun, Z., Zeng, W., Hu, Y., Luk, K. C., Liu, C., Xiang, S., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.019 · Cited by 28

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

Lloyd, G. M., Sorrentino, Z. A., Quintin, S. S., Gorion, K.-M. M., Bell, B. M., Paterno, G., Long, B., Prokop, S., & Giasson, B. I. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02425-4 · Cited by 28

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein

Seetaloo, N., Zacharopoulou, M., Stephens, A. D., Schierle, G. S. K., & Phillips, J. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03183 · Cited by 27

Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease

Henrı́quez, G., & Narayan, M. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00048 · Cited by 27

Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein

Williams, J. K., Yang, X., Atieh, T. B., Olson, M. P., Khare, S. D., & Baum, J. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.024 · Cited by 27

In‐Cell NMR Spectroscopy of Intrinsically Disordered Proteins

Sciolino, N., Burz, D. S., & Shekhtman, A. G. (2018) · PROTEOMICS · doi:10.1002/pmic.201800055 · Cited by 27

Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein

Gotte, G., Donadelli, M., Laurents, D. V., Vottariello, F., Morbio, M., & Libonati, M. (2006) · Biochemistry · doi:10.1021/bi060933t · Cited by 27

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons

Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 27

The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates

Creekmore, B. C., Chang, Y., & Lee, E. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab039 · Cited by 28

Elucidation of Secondary Structure and Toxicity of α-Synuclein Oligomers and Fibrils Grown in the Presence of Phosphatidylcholine and Phosphatidylserine

Dou, T., Matveyenka, M., & Kurouski, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00314 · Cited by 26

Can Intrabodies Serve as Neuroprotective Therapies for Parkinson's Disease? Beginning Thoughts

Bhatt, M. A., Messer, A. C., & Kordower, J. H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130252 · Cited by 26

Identification of an amyloid fibril forming peptide comprising residues 46–59 of apolipoprotein A‐I

Wong, Y. Q., Binger, K. J., Howlett, G. J., & Griffin, M. D. W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.007 · Cited by 26

Intrabody and Parkinson's disease

Zhou, C. H., & Przedborski, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.001 · Cited by 28

Photo‐activity induced by amyloidogenesis

Tcherkasskaya, O. (2007) · Protein Science · doi:10.1110/ps.062578307 · Cited by 28

The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation

Rezaeian, N., Shirvanizadeh, N., Mohammadi, S., Nikkhah, M., & Arab, S. S. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.09.015 · Cited by 26

Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation

Ranjan, P., Ghosh, D., Yarramala, D. S., Das, S., Maji, S. K., & Kumar, A. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.043 · Cited by 25

A subset of calcium‐binding S100 proteins show preferential heterodimerization

Spratt, D. E., Barber, K. R., Marlatt, N. M., Ngo, V., Macklin, J. A., Xiao, Y., Konermann, L., Duennwald, M. L., & Shaw, G. S. (2019) · FEBS Journal · doi:10.1111/febs.14775 · Cited by 25

The effect of amino acid substitution in the imperfect repeat sequences of α-synuclein on fibrillation

Harada, R., Kobayashi, N., Kim, J., Nakamura, C., Han, S.-W., Ikebukuro, K., & Sode, K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.010 · Cited by 27

Synuclein Proteins of the Pufferfish Fugu rubripes: Sequences and Functional Characterization

Yoshida, H., Craxton, M., Jakes, R., Zibaee, S., Tavaré, R., Fraser, G. M., Serpell, L. C., Davletov, B. A., Crowther, R. A., & Goedert, M. (2006) · Biochemistry · doi:10.1021/bi051993m · Cited by 25

Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease

Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24

Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation

Navale, G. R., Ahmed, I., Lim, M. H., & Ghosh, K. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401991 · Cited by 24

Sizes, conformational fluctuations, and SAXS profiles for intrinsically disordered proteins

Mugnai, M. L., Chakraborty, D., Nguyen, H. T., Maksudov, F., Kumar, A., Zeno, W. F., Stachowiak, J. C., Straub, J. E., & Thirumalai, D. (2025) · Protein Science · doi:10.1002/pro.70067 · Cited by 24

Aggregation of α-synuclein splice isoforms through a phase separation pathway

Röntgen, A., Toprakcioglu, Z., Dada, S., Morris, O. M., Knowles, T. P. J., & Vendruscolo, M. (2025) · Science Advances · doi:10.1126/sciadv.adq5396 · Cited by 25

Unravelling the inhibitory activity of Chlamydomonas reinhardtii sulfated polysaccharides against α-Synuclein fibrillation

Choudhary, S., Save, S. N., & Vavilala, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-24079-7 · Cited by 25

Re-designing the α-synuclein tetramer

Xu, L., Bhattacharya, S., & Thompson, D. (2018) · Chemical Communications · doi:10.1039/c8cc04054k · Cited by 24

Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity

Hmila, I., Vaikath, N. N., Majbour, N. K., Erskine, D., Sudhakaran, I. P., Gupta, V. R., Ghanem, S. S., Islam, Z., Emara, M. M., Abdesselem, H., et al. (2022) · FEBS Journal · doi:10.1111/febs.16376 · Cited by 24

Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations

Patrias, L. M., Klaver, A. C., Coffey, M. P., & Loeffler, D. A. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04214.x · Cited by 24

Molecular Mechanisms of the Bindings between Non-Amyloid β Component Oligomers and Amylin Oligomers

Atsmon‐Raz, Y., & Miller, Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b07731 · Cited by 24

The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome

Park, H., Ryu, D. H., Parmar, M. S., Giasson, B. I., & McFarland, N. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184262 · Cited by 24

Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Andrikopoulos, N., Li, Y., Cecchetto, L., Nandakumar, A., Ros, T. D., Davis, T. P., Velonia, K., & Ke, P. C. (2020) · Nanoscale · doi:10.1039/d0nr04273k · Cited by 24

Dopamine differentially induces aggregation of A53T mutant and wild type α-synuclein: Insights into the protein chemistry of Parkinson’s disease

Moussa, C., Mahmoodian, F., Tomita, Y. A., & Sidhu, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.075 · Cited by 24

Ubiquitination of alpha-synuclein filaments by Nedd4 ligases

Mund, T., Masuda‐Suzukake, M., Goedert, M., & Pelham, H. R. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200763 · Cited by 25

The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity

Wu, M., Su, H., & Zhao, M. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00332-2 · Cited by 23

Passive Immunization in Alpha-Synuclein Preclinical Animal Models

Folke, J., Ferreira, N., Brudek, T., Borghammer, P., & Berge, N. V. D. (2022) · Biomolecules · doi:10.3390/biom12020168 · Cited by 23

Label-Free Characterization of Amyloids and Alpha-Synuclein Polymorphs by Exploiting Their Intrinsic Fluorescence Property

Chung, C. W., Stephens, A. D., Ward, E., Feng, Y., Davis, M. J., Kaminski, C. F., & Schierle, G. S. K. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05651 · Cited by 23

Bis-chalcone polyphenols with potential preventive and therapeutic effects on PD: Design, synthesis and in vitro disaggregation activity against α-synuclein oligomers and fibrils

Jiang, B., Han, F., Lü, M.-H., Wang, Z., Liu, W., Zhang, Y., Xu, J. P., & Li, R.-J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114529 · Cited by 23

Residue Glu83 plays a major role in negatively regulating α-synuclein amyloid formation

Waxman, E. A., Emmer, K. L., & Giasson, B. I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.079 · Cited by 23

Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease

Török, N., Majláth, Z., Szalárdy, L., & Vécsei, L. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1237501 · Cited by 23

DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers

Muñoz, P., & Segura‐Aguilar, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9747-4 · Cited by 23

Exploring the putative role of kallikrein‐6, calpain‐1 and cathepsin‐D in the proteolytic degradation of α‐synuclein in multiple system atrophy

Kiely, A. P., Miners, J. S., Courtney, R. J., Strand, C., Love, S., & Holton, J. L. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12512 · Cited by 23

Segmental 13C‐Labeling and Raman Microspectroscopy of α‐Synuclein Amyloid Formation

Flynn, J. D., Jiang, Z., & Lee, J. C. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201809865 · Cited by 23

Amyloids and their untapped potential as hydrogelators

Belwal, V. K., & Chaudhary, N. (2020) · Soft Matter · doi:10.1039/d0sm01578d · Cited by 23

Aggregation and phase separation of α-synuclein in Parkinson's disease

Han, W., Wei, M., Xu, F., & Niu, Z. (2024) · Chemical Communications · doi:10.1039/d4cc01591f · Cited by 22

Cu2+, Ca2+, and methionine oxidation expose the hydrophobic α-synuclein NAC domain

Ramis, R., Ortega‐Castro, J., Vilanova, B., Adrover, M., & Frau, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.018 · Cited by 22

Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment

Chetty, D., Abrahams, S., van Coller, R., Carr, J. A., Kenyon, C. P., & Bardien, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15324 · Cited by 22

Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09520-7 · Cited by 22

Folding and amyloid‐fibril formation for a series of human stefins' chimeras: Any correlation?

Kenig, M., Kokalj, S. J., Žnidarič, M. T., Pompe‐Novak, M., Gunčar, G., Türk, V., Waltho, J. P., Staniforth, R. A., Avbelj, F., & Žerovnik, E. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20812 · Cited by 22

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3